Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,974 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Right ventricular reverse remodelling after balloon pulmonary angioplasty.
Fukui S, Ogo T, Morita Y, Tsuji A, Tateishi E, Ozaki K, Sanda Y, Fukuda T, Yasuda S, Ogawa H, Nakanishi N. Fukui S, et al. Among authors: fukuda t. Eur Respir J. 2014 May;43(5):1394-402. doi: 10.1183/09031936.00012914. Epub 2014 Mar 13. Eur Respir J. 2014. PMID: 24627536 Free article.
Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.
Ishiyama K, Nakao S, Usuki K, Yonemura Y, Ikezoe T, Uchiyama M, Mori Y, Fukuda T, Okada M, Fujiwara SI, Noji H, Rottinghaus S, Aguzzi R, Yokosawa J, Nishimura JI, Kanakura Y, Okamoto S. Ishiyama K, et al. Among authors: fukuda t. Int J Hematol. 2020 Oct;112(4):466-476. doi: 10.1007/s12185-020-02934-6. Epub 2020 Aug 31. Int J Hematol. 2020. PMID: 32869125 Clinical Trial.
Increased Non-Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan-Based Regimen.
Shinohara A, Shindo M, Nakano N, Sakaida E, Uchida N, Fukushima K, Nakazawa H, Serizawa K, Kanda Y, Kawakita T, Ikeda T, Ohigashi H, Ito A, Wakayama T, Matsuoka KI, Fukuda T, Tanaka J, Atsuta Y, Nakasone H. Shinohara A, et al. Among authors: fukuda t. Eur J Haematol. 2025 Jan 20. doi: 10.1111/ejh.14374. Online ahead of print. Eur J Haematol. 2025. PMID: 39834012
Low survival due to higher risk of relapse and non-relapse mortality after allogeneic HSCT in ATL compared with AML and ALL.
Tomori S, Morishima S, Kato K, Nakasone H, Nakano N, Eto T, Kawakita T, Suehiro Y, Miyazaki Y, Uchida N, Sawayama Y, Mori Y, Nakamae H, Nagafuji K, Uehara Y, Doki N, Kanda J, Fukuda T, Atsuta Y, Yoshimitsu M; JSTCT ATL Working Group and JSTCT Transplant Complications Working Group. Tomori S, et al. Among authors: fukuda t. Transplant Cell Ther. 2025 Jan 17:S2666-6367(25)00909-1. doi: 10.1016/j.jtct.2025.01.882. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39828057
Phase 1 Study of Quercetin, a Natural Antioxidant in Children and Young Adults with Fanconi Anemia (FA).
Mehta PA, Nelson AS, Loveless SK, Lane A, Fukuda T, Teusink-Cross A, Elder D, Lagory D, Miller E, Cancelas JA, Howell J, Zhao J, Mizuno K, Myers KC, Lake K, McIntosh K, Setchell KDR, Luebbering N, Edwards S, Chihanga T, Wells SI, Davies SM. Mehta PA, et al. Among authors: fukuda t. Blood Adv. 2025 Jan 16:bloodadvances.2024015053. doi: 10.1182/bloodadvances.2024015053. Online ahead of print. Blood Adv. 2025. PMID: 39820512
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.
Kawamura S, Nakagawa D, Nagayama T, Katayama Y, Doki N, Takeda W, Nishida T, Matsuoka KI, Ikeda T, Ohigashi H, Sawa M, Fukushima K, Kanda J, Serizawa K, Onizuka M, Fukuda T, Atsuta Y, Kanda Y, Nakasone H. Kawamura S, et al. Among authors: fukuda t. Blood Adv. 2025 Jan 14:bloodadvances.2024014408. doi: 10.1182/bloodadvances.2024014408. Online ahead of print. Blood Adv. 2025. PMID: 39808797
4,974 results